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Avian bornaviral ganglioneuritis, often referred to as parrot wasting disease, is associated with a newly discovered avian virus from
the taxonomic family Bornaviridae. Research regarding the pathogenesis and treatment for this disease is ongoing, with implications for understanding other emerging human and nonhuman diseases, as well as the health and ecology of wildlife. At this
time, numerous questions remain unanswered regarding the transmission of the disease, best practices for diagnostic sampling
and testing, and whether currently used drug therapies are eﬀective or harmful for aﬄicted birds. The pathogenesis of the disease
also remains unclear with many birds showing resistance to the eﬀects of the virus and being able to remain clinically unaﬀected
for years, while other birds succumb to its eﬀects. New research ﬁndings regarding avian bornaviral ganglioneuritis are discussed
and important as yet unanswered questions are identiﬁed.

1. Introduction
Recently, there have been major advances in our understanding
of avian bornaviral ganglioneuritis (ABG), sometimes called
parrot wasting disease, including research about its causes,
transmission, diagnostic testing, and treatment with implications
for human medicine and the veterinary care of other animal
species. It was previously referred to as proventricular dilatation
disease (PDD) because symptoms can involve gastrointestinal
crisis; the disease is now understood to have more extensive
nervous system involvement, so it is more often referred to as
avian bornaviral ganglioneuritis (ABG). There is also new evidence of a similar condition referred to as avian ganglioneuritis
(AG), depending on whether the animal tests positive for the
bornaviruses. Advances in our knowledge about the treatment
and prevention of viral diseases such as the avian bornaviruses
have important implications for veterinary practices, as well as
the global ecology and the potential spread of zoonotic diseases.

2. Symptoms of the Disease
Clinical symptoms vary in both severity and type across
individual birds, but they appear to be neurological in origin

with clinical signs related to their eﬀects on the digestive
system and the nervous system. Gastrointestinal (GI) signs
may involve excessive regurgitation, poor appetite, crop
impaction, weight loss, and passage of undigested food in the
feces. These symptoms may be related to pathology of the
vagus nerve that controls the upper part of the digestive
tract, including the crop, proventriculus, and ventriculus,
resulting in reduced gastrointestinal motility [1]. Some researchers have also suggested that the interstitial cells of
Cajal that control muscular movements in the digestive
system are likely to be involved as the target of avian bornaviruses [2]. Regardless, with progression of the disease and
high susceptibility, there can be paralysis of the intestines
with food becoming stuck in the bird’s proventriculus, a rodshaped organ in the bird’s digestive system located between
the crop and the gizzard. With dysfunction of the vagus
nerve or other digestive processes, this portion of the intestines can swell with blocked food and then rupture,
resulting in a bird’s painful death. Therefore, bornavirus
infection should be suspected if there are weight loss, undigested food in the bird’s droppings, vomiting, abdominal
extension, and moaning with physical discomfort [3].
Bornaviruses can spread through other parts of a bird’s
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nervous system and cause shaking of the head, abnormal and
uncoordinated movements, diﬃculty balancing, tremors,
paralysis, self-mutilation, aggression, and seizures. There
may also be heart arrhythmias, blindness, and cognitive
deﬁcits, depending on the various locations of neurological
damage [1, 4]. A survey of 32 bornavirus-positive birds from
Brazilian clinics and breeding facilities, including several
conﬁscated from illegal trade, revealed that 66% of aﬄicted
birds showed CNS symptoms, while 22% had GI signs, and
9% of the birds died [5]. Some new evidence also suggests
that feather-plucking is associated with this disease. In a
study of 126 birds in a private veterinary practice in Germany, antibody titers and viral shedding were highest for
birds with neurological signs of the disease, second highest
for feather-plucking birds with no other neurological signs,
and lowest for a control group without neurological signs or
feather-plucking [6].

3. What Are the Bornaviruses?
It is commonly accepted today that parrot wasting disease or
avian bornaviral ganglioneuritis can be caused by avian
bornavirus infection. In 2008, parrot wasting disease was
shown to be associated with a newly discovered virus, i.e., the
avian bornaviruses which shared only 70% of their nucleotide sequence with the previously identiﬁed mammalian
bornaviruses [7, 8]. Bornaviruses, members of the taxonomic family Bornaviridae, were named after the town
called Borna in eastern Germany which had historically high
occurrences of neurological disease outbreaks in horses and
sheep. An epidemic among cavalry horses occurred between
1894 and 1896 with symptoms such as head-tilting, paralysis,
aggression, and diﬃculties with chewing and swallowing.
Research has shown that the virus occurs at a higher than
normal frequency in both horses and sheep in this region,
although bornaviruses occur in many other species of birds
and mammals and in many other parts of the world, although it is diﬃcult to assess the prevalence of the virus
across species/geographic regions because blood testing
procedures are not standardized, i.e., sample collections of
serum vs. whole blood, testing for the presence of the virus
itself or antibodies to the virus [9]. Bornaviruses consist of
enveloped nonsegmented viruses with negative-stranded
RNA genomes of approximately 8,900 bases (NNN). Replication and transcription of these viruses take place in the
nuclei of cells, speciﬁcally nerve cells. As RNA viruses, they
lack the enzymatic corrective mechanisms in replication that
characterize DNA viruses. Without corrective mechanisms,
RNA viruses are more likely to have changes in their genetic
makeup so that the production of eﬀective vaccines may
become more diﬃcult [10]. The impact of bornavirus infection appears to depend on the body’s immunological
responses because the presence of CD3+ host T cells in the
brain has been shown to be strongly associated with the
onset of neurological symptoms [11]. Furthermore, research
has shown that the amount of virus detected in tissues after
death is not associated with severity of clinical symptoms,
supporting the conclusion that the body’s immune response
is a causal factor in the disease, although the speciﬁc
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pathogenic mechanisms are currently under debate by researchers [1, 2].

4. Transmission of Avian Bornaviruses
The transmission of bornaviruses from one bird to another is
not fully understood. It makes sense to expect the disease to
be transmitted horizontally through direct contact or
through ingestion of an infected bird’s urofecal matter.
Research has demonstrated that aviaries with infected birds
may have positive air tests for bornaviruses, presumably as a
result of feather dust; therefore, it has been suggested that the
virus can become aerosolized when infected birds defecate or
regurgitate and then spread as these substances become dry
[3]. On the contrary, investigations of transmission of
bornaviruses in laboratory settings have resulted in inconsistent contagion results for noninfected birds housed in the
same aviaries as infected birds [12]. Some researchers believe
that horizontal transmission requires a long-term and close
contact between birds [13]. Furthermore, unlike research
with the mammalian bornaviruses [14], attempts to inoculate uninfected birds with bornaviruses via mucosal surfaces (nasally and orally) have thus far had inconsistent
results [15]. Instead, successful experimental inoculations of
birds have included intramuscular injection [16], as well as
intracerebral and intravenous injections of the virus [17]. It
remains unclear why there would be such a major diﬀerence
between birds and mammals in the eﬀectiveness of exposure
to the virus through nasal and ocular entry sites [18] or why
these routes would be eﬀective while the virus is believed to
be spread through axonal transport processes [16]. There is
remarkably little speculation about this in the published
literature. Perhaps, it is related to local anatomical or
physiological diﬀerences between these classes of animals,
discussed for chickens vs. mammals [19], or the stability and
viability of the avian bornaviruses in the biological systems
of birds [20]. On the contrary, it may involve diﬀerences in
innate immune system responses, for example, the lack of an
anti-inﬂammatory protein identiﬁed in chickens [21]. Regardless, these are important questions regarding the
transmission of avian bornaviruses and the immune systems
of birds that remain unanswered.
Given the eﬀectiveness of intramuscular and intravenous
injections for bornavirus infection, it may also be speculated
that cutaneous wounds provide opportunities for infection.
Recent reports of three human deaths due to encephalitis
following bites or scratches by variegated squirrels positive
for the mammalian bornaviruses would seem to support this
possibility [22]. Researchers have also examined vertical
transmission of bornaviruses by testing the contents of eggs
laid by infected birds. While the results were positive, this
research has not yet included systematic procedures to allow
the eggs to hatch in order to determine the eﬀects of bornaviruses on parrot hatchlings [23]. Exposure to avian
bornaviruses in unweaned chicks tends to result in a rapidly
high mortality rate compared to older birds, perhaps due to
an undeveloped immune response. To date, one research
study has examined vertical transmission of bornaviruses
from parents to hatched oﬀspring in free-ranging birds (i.e.,
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Canada geese) showing negative results [23]. In sum, although bornaviruses have been observed to have high
contagion in some aviaries, laboratory testing of the spread
of the virus still has not identiﬁed a speciﬁc reliable route of
infection, although some researchers now suggest that
vertical transmission is likely to be shown to be the primary
cause of avian bornavirus transmission [3], despite yet
unanswered questions regarding mortality rates in infected
hatchlings and the current lack of information about the
timing of viral transmission during egg development.

5. Diversity in Subtypes of Avian Bornaviruses
In the 1970s, when scientists became aware of the occurrence
of parrot wasting disease, there were few, if any, regulations
regarding the capture of parrots in their native habitats for
the pet market in the US. These animals were often housed in
large quarantine warehouses that lacked protocols to prevent
the spread of diseases. Many birds suﬀered and died as a
result of these conditions. Without a doubt, there was
enormous stress for these animals associated with being
removed from their families and homes, only to be housed in
cages, often in unhygienic conditions with uncontrolled
mixing of diﬀerent bird species. Interestingly, genetic
analysis does not support the view that parrot bornaviruses
were transferred from waterfowl during this time [24]. Yet,
these stressors likely enhanced vulnerability to the disease
and contributed to the high mortality rates for these birds,
perhaps impacting the subtypes of bornaviruses identiﬁed in
captive parrot populations today. At the last count, researchers mapping the genomes for bornaviruses in birds
have identiﬁed a total of ﬁfteen genotypes of bornaviruses,
12 classiﬁed and 3 unclassiﬁed within the genus Orthobornavirus [25], which can occur in avian species, including
eight found in parrot populations worldwide [15] that share
91 to 100% of their nucleotide sequences within genotypes
and 68 to 85% between genotypes [26]. It has been speculated that the diversity of bornavirus genotypes in captive
parrots compared to free-living waterfowl is the result of the
spread of bornaviruses across species during the unregulated
housing and transport associated with wild captures decades
ago [6]. Genotypes for bornaviruses in parrots do not appear
to be clearly linked to geographical regions unlike bornaviral
genotypes identiﬁed in waterfowl [15]. The genotypes
identiﬁed as most virulent for parrots are subtype numbers 2
and 4 (referred to as PABV-2 and PABV-4), and these are
the usual targets of bornavirus testing for veterinary purposes today [15]. Note that if bornavirus tests are negative
and veterinarians still suspect the disease, then it may be
necessary to expand testing to other subtypes of the virus [3].
Some research ﬁndings with cockatiels revealed diﬀerences
in the eﬀects of these two strains of the virus with PABV-4
associated with more neurological signs, while PABV-2
mainly aﬀected the gastrointestinal tract with more severe
disease progression, although other factors may play a role,
including individual immune responses and how well a virus
is adapted to a particular host species [5]. Simultaneous
presence of both genotypes appears to be associated with
more severe clinical signs with infection with one subtype
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failing to provide protection against the other [13]. On the
contrary, tracking the spread of PABV-2 in individual
cockatiels following intramuscular injections revealed the
presence of the virus at the inoculation site and adjacent
nerves, then in the spinal cord, and ﬁnally in the brain. With
CNS infection, the virus also spread to the gastrointestinal
system, adrenal gland, heart, and kidneys over 114 days of
experimentation [16]. Clearly, additional larger scale studies
with multiple species are required to further investigate the
relationships between bornavirus subtypes, clinical symptoms, and histopathology in captive parrots. It is also well
known that many birds who test positive for bornaviruses,
including PABV-2 and PABV-4, do not show symptoms. In
fact, recent estimates indicate that 10% to 45% of captive
birds are infected, and at least one in three healthy captive
parrots is likely to test positive for bornaviruses. Furthermore, some free-ranging Brazilian parrots in their natural
habitats have been shown to be positive for bornaviruses
[27]. However, others pointed out that these birds had been
housed in rehabilitation centers for weeks, allowing for
infection during this time period [15]. Clearly, more ﬁeld
studies are needed with long-term tracking of infected birds
combined with genetic studies of viral subtypes.

6. Is It an Immune or Autoimmune Response?
Another important debate about avian ganglioneuritis involves the pathogenic mechanisms for this disease. It is
generally believed that avian bornaviruses aﬀect the body’s
immunological response because CD8+ host T cells in the
brain are strongly associated with the onset of neurological
symptoms and the amount of virus detected in tissues after
death is not associated with severity of clinical symptoms [1].
Speciﬁcally, CD8+ T cells cause direct damage to the ganglia
and neurons, combined with CD4 T-cell recruitment of
macrophages, ultimately resulting in antibody-mediated
phagocytosis of axons [1]. Less direct mechanisms including
loss of protective myelin, dysfunction of mitochondria, and
release of nitric oxide or glutamate may contribute to axonal
damage [1]. Both innate and adaptive immune responses
appear to be involved because complement components C1
and C3 tend to be present inside avian bornaviral lesions,
suggesting that both the classic and alternative complement
cascade pathways are activated, respectively [1]. However,
the alternative or innate pathway can be triggered as a
function of foreign substances and damaged tissues, thereby
amplifying the activation cascade. Some researchers have
suggested that an autoimmune response may be involved as
host antibodies attack gangliosides located in neural cell
membranes. In 1942, Ernst Klenk ﬁrst used the term
“ganglioside” to describe lipids isolated from ganglion cells
in the brain. Today, we know that gangliosides are primarily
located in the nervous system and that they are microscopic
structures that protrude through the surface of the cell to act
as surface markers for cellular recognition and cell-to-cell
communication [28]. Rossi and his colleagues suggested that
an autoimmune mechanism may occur with inﬂammation
of the nerve ganglia causing exposure of normally protected
proteins (i.e., gangliosides) to the host immune system in a
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fashion comparable to Guillain–Barré syndrome in humans
[1]. Recently, researchers in the Netherlands published a
paper outlining the role of these cell structures as modulators of immune functioning [29]. However, de Araujo et al.
argued that Guillain–Barré syndrome is associated with
peripheral neuropathy and limb weakness which are not
primary features of proventricular dilatation disease [30].
They suggested that ambulatory dysfunction in aﬄicted
birds, if it occurs, is more likely due to CNS lesions. They
further pointed out that macrophages play an essential role
in the development of nerve lesions in Guillain–Barré
syndrome, speciﬁcally causing demyelination which is not
characteristic of proventricular dilatation disease in parrots.
In order to test for autoimmunity as a causal factor for the
disease, these researchers inoculated healthy chickens and
Quaker parrots with brain gangliosides or crude nervous
system extracts via the pectoral muscles and reported that it
did not result in clinical signs of the disease after 114 days
[30]. However, in a criticism of this work, Rossi et al. indicated that some of these birds did exhibit some pathological signs of the disease, but they were discounted by the
researchers as naturally occurring lesions in the gastrointestinal tract or CNS of avian species which occur with
inoculations of foreign substances [1]. Rossi and his colleagues further pointed out that one chicken was reported to
develop a mild diﬃculty walking and two of ﬁve parrots
showed mild depression, while a third parrot evidenced
weight loss, and one parrot was observed to have depressive
symptoms [1]. Notably, the parrot with weight loss had the
highest titers for antiganglioside antibodies tested with
ELISA [1]. In contrast, Rossi and his colleagues described
their experiments in which young cockatiels were inoculated
with gangliosides extracted from the CNS of uninfected
parrots and reported that it resulted in clinical signs of the
disease and typical histological lesions, as well as high
ganglioside antibody titers [1]. This suggests that the disease
can be manifested in the absence of bornaviruses when there
is comparable damage to the nervous system. As these researchers indicated, it is not yet clear how antiganglioside
antibodies contribute to the progression of disease, but
investigations of autoimmune involvement may allow for a
clearer understanding of the complex pathogenesis of this
disease, and one might speculate that it could help explain
the high levels of individual variability among parrots in
susceptibility to the disease [1]. Other researchers have
concluded that some individual parrots may exhibit transient autoimmune responses to the disease, stating that they
are not a common response [31].

7. Diagnostic Testing for Avian Bornaviruses
Deﬁnitive diagnoses of the disease in living birds involve
examination of histological lesions during biopsies or the use
of radiology/ultrasonography to reveal the appearance of
structures in the gastrointestinal tract [13]. Yet, bird owners
tend to be concerned about the stress for their pets during
such procedures, particularly if sedation is required. Furthermore, according to some researchers, only about 76% of
birds with this disease have crop lesions and false-negative
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crop biopsy results tend to occur about 24% of the time [32].
Other researchers have reported a high level of variability
between aﬄicted birds regarding locations of lesions in the
gastrointestinal tract [33]. Thus, less invasive diagnostic
testing tends to be preferred by both veterinarians and parrot
owners, although low reliability and lack of standardization
of laboratory tests remain an issue today [1].
7.1. Sample Collection. Diagnostic testing may involve
swabbing the cloaca or collecting a bird’s droppings, but
these tests have limited usefulness due to variability among
birds in how often the virus is shed through these routes.
Some infected birds may consistently shed the bornaviruses,
while others do so intermittently [4]. In fact, a single negative test in this context is typically not considered meaningful, so veterinarians and testing laboratories may
recommend that samples be collected in a single container
three times at weekly intervals [34]. Other testing laboratories may require other sample types such as the submission
of whole blood and a cloacal swab to test for bornaviruses
[35]. In their discussion of avian bornavirus diagnostics,
Rossi et al. recommended that whole blood be sampled, in
addition to choanal/cloacal swabs, but not fecal samples.
Another potential diagnostic sampling technique involves
testing the calami of plucked contour feathers [36]. The
calamus of a feather is the tube at the base of a feather below
the colored barbs. A contour feather is one that is located on
the body of a bird, rather than the wings or tail. This type of
sampling may be more sensitive because it is less likely to be
aﬀected by contaminants or by substances in blood and
urofecal matter that can inhibit the test results. Furthermore,
evidence suggests that feathers stored in baggies at room
temperature for four weeks can remain useful for diagnostic
testing. On the contrary, critics have pointed out that testing
with feathers may lead to false positives due to contamination from other birds sharing the environment. Therefore,
testing of plucked feathers may be more useful for detecting
the presence of avian bornaviruses in aviaries or grouphoused parrots rather than for individual birds [37].
However, plucking feathers is painful for birds, particularly
when test laboratories require multiple feathers to be
plucked (e.g., 4 to 8 feathers) [38]. In contrast, blood testing
is a well-accepted veterinary procedure with parrots that
theoretically at least allows for detection of the virus, detection of avian bornavirus antibodies, or genetic testing for
subtypes of the avian bornaviruses. To conclude, veterinarians need to examine the sampling protocols of speciﬁc
diagnostic laboratories which often vary in whether whole
blood, serum, or plasma samples should be collected to
conduct blood tests for avian bornaviruses. Hopefully,
further research will reveal an optimum sampling protocol
that can then be standardized across laboratories.
7.2. Diagnostic Assessments. The current recommended
procedure for avian bornavirus testing is the reverse transcription polymerase chain reaction (RT-PCR) test, preferably in real time to monitor the progress of the PCR [1].
This is a two-step process involving reverse transcription to
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synthesize the genetic material and a polymerase chain
reaction to amplify speciﬁc genetic targets [1, 37]. However,
these tests typically only test for one or two speciﬁc subtypes
of the virus, and there may, in fact, be other subtypes that
remain to be discovered. At this time, there is no reliable
ELISA (enzyme-linked immunosorbent assay) commercially
available for detecting avian bornavirus antigens or antibodies from blood samples [39]. Researchers have pointed
out that not all birds react strongly to the avian bornavirus
antigen and therefore ELISA tests tend to lack speciﬁcity
[37], and others have recommended a combination of RTPCR and the western blot test to identify infected parrots
[33], although the indirect ﬂuorescent antibody (IFA) test
tends to be used in Europe more often than the western blot
test [1]. Both antibody tests, i.e., the western blot and the IFA
test, are considered sensitive and speciﬁc, but they do not
distinguish between diseased birds and healthy carrier birds
[1]. Furthermore, there are discrepancies between viral
shedding, the presence of antibodies, and clinical signs of the
disease, with university and commercial laboratories ranging
from 3 to 33% in positive avian bornavirus test results [1].
Instead, according to Rossi and his colleagues, serologic
testing for antiganglioside antibodies may ultimately provide
more accurate testing, given their reports that 98% of
clinically symptomatic and histologically positive birds had
elevated antiganglioside antibody levels in 650 avian serum
samples [1]. It is possible that testing for antiganglioside
antibodies may prove more reliable than directly testing for
the virus or antibodies to the virus. Clearly, research in this
context is ongoing and necessary.

8. Care and Treatment of Afflicted Parrots
Strong evidence suggests that birds with bornavirus infections can remain clinically healthy for decades [11],
particularly if supportive care is provided. However, the
identiﬁcation of bornavirus-positive birds should be followed by containment, quarantining infected birds, and
then conducting a thorough cleaning of infected aviaries.
Fortunately, the avian bornavirus is not long-lived in the
environment, and its spread can be limited by good hygiene
and ultraviolet light. Research shows that the avian bornaviruses can be detected in the air of aviaries with infected
birds. Researchers have described laboratory testing of air
ﬁlters from dry-ﬁlter (DFR 1000) units which were consistently positive for the virus [31]. However, bornaviruses
can be inactivated with chlorine-containing disinfectants
[40], and research suggests that allowing infected cages to
dry thoroughly before reuse is eﬀective for removing avian
bornaviruses. Speciﬁcally, in vitro testing revealed that 8
and 24 hours of drying reduced the amount of infectious
virus by 48 and 86%, respectively [41]. Although they are
believed to be stable at neutral pH and able to withstand
both acidic and alkaline solutions, bornaviruses become
rapidly less infective with heat treatment at 56 degrees
Celsius (or 132.8 degrees Fahrenheit) and are relatively
stable at 37 degrees Celsius (or 98.6 degrees Fahrenheit)
[42]. It is important to emphasize that parrots that test
positive for these viruses should not be euthanized because
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they can live for years without clinical symptoms of the
disease. Daily care of birds with clinical symptoms of
bornaviruses consists of providing an easily digestible, high
energy diet, including banana, the mashed inside of potatoes or yams, rice, canned pumpkin, frozen peas, and
scrambled eggs. On the contrary, seeds, nuts, strawberries,
and the skin of fruits such as apples should be avoided
because they are more diﬃcult to digest. For this reason,
some experts [13] also recommend semielemental diets
designed to be highly nutritious and easily digestible for
compromised birds [43]. Others have suggested that it may
be beneﬁcial to supplement the diets of birds in early stages
of the disease with vegetables high in ﬁber because it may
stimulate intestinal motility, while the same foods are
undesirable for birds with more progressive symptoms
because they may remain in the intestines and ferment [44].
While it is not yet clear what triggers the actual development of clinical signs in an infected bird, environmental
stressors are likely to play a role and there is no doubt that a
good diet is beneﬁcial, as is some exposure to sunlight and
good hygiene.
8.1. Currently Used Drug Therapies. Current veterinary
treatments for birds that show clinical symptoms include
anti-inﬂammatory drugs such as celecoxib, also known as
Celebrex [45], a nonsteroidal pain-relieving anti-inﬂammatory drug, produced in a variety of ﬂavors such as
pumpkin or strawberry which can be attractive to parrots.
Depending on how easily a bird can be handled, medication
can be placed directly inside the bird’s beak or added to its
food or water. An alternative drug used to treat this disease
is meloxicam [46]. Celebrex and meloxicam are both
nonsteroidal anti-inﬂammatory drugs (NSAIDs) that inhibit cyclooxygenase (COX) isozymes, categorized as COX1 (cyclooxygenase 1, i.e., the innate maintenance form of
enzyme in the immune system that is present in most cells
and tissues important for maintaining the integrity of the
gastrointestinal mucosa, renal blood ﬂow, and platelet
aggregation) and COX-2 (cyclooxygenase 2) which is the
inducible form of enzyme that is responsive to inﬂammatory stimuli and injury [47]. All NSAIDs are COX-2
inhibitors with some degree of COX-1 inhibition [48].
Celebrex is thought to be more selective to COX-2 enzymes
than meloxicam and to have less eﬀect on COX-1 processes
[47]. Although Miesle stated that “. . .only one, Celebrex,
has shown continual, long-term relief from gastrointestinal
and Central Nervous System signs,” (p. 22) [7], the use of
these anti-inﬂammatory drugs is still under debate and
published citations of evidence about drug eﬀectiveness are
sometimes inaccurate and confusing [1, 3]. However,
Dahlhausen et al. [49] published a brief description of eight
cases of the disease in Watchbird, the Journal of the
American Federation of Aviculture in which they described
the results of treating aﬄicted parrots with Celebrex. They
stated that, at therapeutic doses (10 mg/kg orally once
daily), Celebrex does not aﬀect COX-1 processes and that
the drug was well tolerated and safe for the birds. They
further stated that drug administration continued for 6 to
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12 weeks until the birds returned to normal body weights,
conditions, and diets. This occurred even for birds that
were in advanced stages of the disease. If the birds were
removed from the drug therapy and then showed the return
of clinical signs, then they were successfully treated by
restarting the drug. Dahlhausen et al. [49] further indicated
that clinical conditions of these aﬄicted birds tended to
improve within the ﬁrst week of therapy with gradual
resolution of clinical symptoms. No adverse side eﬀects
were reported for these birds either during or following
treatment, and one of these parrots had completed therapy
for 1 1/2 years. On the contrary, other veterinarians have
recommended a daily use of 20 mg/kg oral doses for
aﬄicted birds, although the dosage may be doubled for
birds that are diﬃcult to handle requiring the medicine to
be added to their food [44]. These veterinarians also indicated that there were treatment failures as a result of
batches of the drug that were not used quickly because the
stability of Celebrex in water was unknown; therefore, they
recommended that new stocks be prepared weekly and the
drug be stored with refrigeration [44, 50]. Furthermore,
they reported that these treatments resulted in side eﬀects
of gastrointestinal bleeding for some birds and the development of hypersensitivity to the drug in a hyacinth
macaw, pointing out that the drug is counterindicated for
birds with renal disease because most NSAIDs are eliminated through renal clearance [44, 50]. However, it remains
unclear what the mortality rates would have been without
drug treatment and what percentage of the birds would
have improved under natural conditions. Deﬁnitively resolving these issues would require more systematic investigations, preferably with matched controls, which are
diﬃcult to conduct in veterinary practices.
On the contrary, the use of these anti-inﬂammatory
drugs to treat aﬄicted parrots has been criticized, with one
researcher suggesting that there is limited, if any, eﬀectiveness of using Celebrex and meloxicam and also
pointing out that there can be serious side eﬀects such as
gastrointestinal irritation and bleeding [47]. In fact,
treatment of the disease with meloxicam in cockatiels was
reported to cause disease symptoms to worsen in cockatiels
[51]. Following systematic investigations of drug eﬀectiveness, Escandon reported that the use of these anti-inﬂammatory drugs (i.e., both Celebrex and meloxicam) did
not alter the progression of the disease, the severity of
clinical symptoms, pathological changes in viral RNA
distribution, or viral shedding in cockatiels after experimental inoculation with the avian bornaviruses [47]. She
therefore concluded that there is “. . .no justiﬁcation for
continuing the practice of administering NSAIDs to birds
with clinical PDD” (proventricular dilatation disease, p. 39)
and stated that “. . .unless proven otherwise NSAID use in
PDD cases should be discontinued immediately” (p. 40)
[47]. However, an examination of some online veterinary
services reveals that both drugs are currently recommended
for treatment of the disease [52, 53]. Other veterinary
websites indicate that long-term, albeit low dosage, drug
treatments are recommended [52]. In contrast, Dahlhausen
et al. recommended that aﬄicted birds be taken oﬀ these
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drugs when symptoms abate [49]. Therefore, if anti-inﬂammatory drugs are prescribed, veterinarians and parrot
owners need to make decisions regarding the long-term use
of these drugs or whether to merely administer these drugs
during ﬂare-ups of symptoms.
An additional immunosuppressant drug has recently
been tested for its eﬀectiveness in treating avian bornavirus
disease. According to researchers, the use of cyclosporine, a
drug used in humans to treat autoimmune diseases and to
prevent organ rejection during transplants, resulted in a
reduction of clinical symptoms in cockatiels, albeit with
large amounts of virus remaining in the body [54]. Other
researchers have investigated the eﬀects of ribavirin, a drug
that reduces RNA replication across a broad array of RNA
viruses, and showed that it reduced, but did not eliminate,
viral replication in vitro for both mammalian and avian
cells, especially if combined with type 1 interferon known
to help regulate the immune system [55]. In Japan, researchers have tested the eﬀects of favipiravir (T-705), an
antiviral drug known to be eﬀective against viruses that
cause human hemorrhagic fevers, again in vitro and observed that it reduced both mammalian and avian bornaviruses, although at relatively high doses [56]. It remains
to be seen if these in vitro ﬁndings will transfer to in vivo
testing without harm to the test animals. To conclude,
additional systematic research is necessary to clarify optimal treatment protocols based on the speciﬁc symptoms
and disease progression in individual birds.
8.2. Dietary Supplements. There appears to be less controversy regarding the use of gastrointestinal prokinetic agents
to improve digestive processes and antibacterial and antifungal testing and therapy due to the disease-altered gastrointestinal microbiome, probiotics and prebiotics to help
restore the normal intestinal environment, and omega fatty
acids and herbal supplements such as milk thistle to reduce
inﬂammation (see Dahlhausen and Orosz, 2015, for a detailed formulary) [13].
8.3. Vaccination. In an ideal world, treatments for avian
bornavirus disease would help a bird’s immune system
resist the eﬀects of the virus, as well as eliminate the virus
from the body of the bird, and vaccines could be developed
to prevent the onset of symptoms. The development of
vaccines for avian bornaviruses is currently in its infancy
with a few studies to date showing progress toward this
goal. On the contrary, mammalian bornaviruses have been
extensively studied, and research using laboratory rats has
shown that mammalian bornaviral disease is related to
T-cell activity with immunosuppressive drugs providing
eﬀective treatments, speciﬁcally with surviving rats having
Type 2 immune responses, while the rats that died showed
Type 1 immune responses [54]. Therefore, some researchers have speculated that vaccines for bornaviruses
that are designed to aﬀect the type of immune response may
be more eﬀective than vaccines that directly aﬀect virus
levels [54]. Hameed and colleagues (2018) provided some
support for this approach by vaccinating cockatiels with a
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killed parrot virus plus recombinant PPaBV-4 nucleoprotein (N) in alum, thereby protecting these birds against
a virulent bornavirus isolate (PPaBV-2), but without reduction of viral levels in the organs at necropsy [54]. They
speculated that this would limit the commercial use of this
vaccination protocol, although modifying the dose or
immunization schedule could yield more desirable results.
On the contrary, Runge and colleagues (2016) described experiments with cockatiels and canaries using live
viral vector vaccines carrying the N and P genes of avian
bornaviruses and a heterologous prime-boost vaccination
regime that yielded positive tests for antibodies reactive to
the virus [57]. However, the progress of the disease was
delayed in these birds, not prevented, following exposure
to a high viral challenge dose of avian bornaviruses [57].
They pointed out that, without fuller knowledge regarding
the transmission of avian bornaviruses, it is diﬃcult to
identify the appropriate routes and viral dosages to use
when testing new vaccines [57]. These researchers speculated that naturally occurring infections of the disease
may involve lower challenge dosages. They therefore
conducted additional experiments using 10-fold lower
dosages of challenge infections and second booster vaccinations which appeared to be successful in protecting
these birds against viral infection with reduced clinical
signs, fewer gross lesions, and only one bird showing
mononuclear inﬁltrations while also lowering viral loads
in these birds [57].
Clearly, while parrot owners around the world eagerly
await a fully eﬀective treatment for this disease, the research
is ongoing. It may be that additional studies exploring
modiﬁcations in existing vaccination protocols will lead to
the successful prevention of the disease, or it may be that
furthering our knowledge about the functioning of microscopic cellular structures such as gangliosides will play a role
in future treatment successes. Perhaps, a deeper understanding of genetic coding and disease transmission will
provide this much needed research breakthrough. Some
experts have suggested that birds that are positive to the
virus may have a natural immunity to the disease and
therefore may be the best breeders for the avicultural
community [44]. This assumes that clinical dormancy for
this disease in parrots has high heritability which is actually
unknown at this time. But, it may be useful to investigate
genetic diﬀerences between healthy carriers and parrots that
succumb to the disease. In humans, some individuals,
particularly northern Europeans, have been discovered to
have a natural immunity to HIV when they are homozygous
carriers of a mutated gene that changes the size and position
of the receptors which prevents HIV from entering their cells
[58]. Therefore, HIV researchers are hopeful that investigations of disease-resistant individuals or populations,
combined with further understanding of genomic coding,
will contribute to the development of new strategies for
developing HIV vaccinations [59]. Likewise, veterinarians
and bird owners remain hopeful that new strategies for
vaccine development will prove successful for treating avian
bornaviral ganglioneuritis and ultimately other emerging
viral diseases in the future.
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9. The Importance of Bornavirus
Research across Species
It is common knowledge among bird experts and veterinarians that the avian bornaviruses are not harmful to
humans and that they do not grow in mammalian tissue in
laboratories. In fact, researchers studying the evolution of
bornaviruses have suggested that avian bornaviruses diverged from their ancestral version about 300 years ago
[24]. Thus, one may conclude that this divergence in genetic material involved mutations that produced an avian
bornavirus that is incompatible with human physiology.
On the contrary, mammalian bornaviruses that infect a
variety of species, including horses, sheep, cattle, rhesus
monkeys, and rodents, can be transmitted between animals and humans. Recently, mammalian bornaviruses
were shown to be associated with encephalitis and deaths
in three people in Germany with variegated squirrels bites
identiﬁed as the source of transmission [22]. Mammalian
bornaviruses have also been under scrutiny for possible
roles in the development of depression, bipolar disorder,
and other psychiatric disorders because the virus appears
to target the limbic system which plays a dominant role in
our emotions. While some research has supported this
view [60], other researchers have been critical, suggesting
that investigations with better control conditions failed to
reveal bornaviruses in psychiatric patients with mood
disorders [9, 61]. Still other researchers have expressed
concern about the possibility of mammalian bornaviruses
being spread through human organ transplants, given the
possibility of their association with psychiatric disorders
and the recent cases of encephalitis transmitted by variegated squirrel bites [62]. Clearly, the bornaviruses remain an important focus for researchers worldwide who
are seeking knowledge on and remedies for diseases in
humans and other animals. Importantly, avian bornaviruses are prevalent in various ecological systems around
the world, having been detected in a variety of species of
birds other than parrots, including waterfowl, raptors, and
passerines, therefore aﬀecting numerous swans, geese,
gulls, and wild ducks [2, 11]. Mammalian bornaviruses
have also been found in a variety of other animals in their
natural habitats, including rodents and snakes [63, 64].
Clearly, there are numerous natural reservoirs for the
various types of bornaviruses.
Researchers continue to monitor occurrences of the
various types of bornaviruses in the global natural environment, also seeking eﬀective treatments for bornavirustransmitted diseases. It seems likely that acquiring a fuller
understanding of the prevalence, transmission, and treatment of emerging or reemerging diseases will be beneﬁcial as
we encounter new ones in the future. The ongoing research
regarding avian and other bornaviruses has enormous importance for treating our aﬄicted pets, as well as for protecting humans from zoonotic diseases.
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